活跃临床试验中的黑色素瘤脑转移患者的入学趋势
Omar Elghawy1, Reema Patel2, Jason Xu1
1Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Cancer investigation
|May 22, 2024
概括
大多数临床试验都不包括患有黑色素瘤大脑转移 (MBM) 的患者,这阻碍了获得新疗法的机会. 重新考虑试验设计对于改善这些患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 神经瘤学神经瘤学
背景情况:
- 中枢神经系统 (CNS) 的参与在黑色素瘤中很常见,往往导致治疗失败.
- 黑色素瘤大脑转移 (MBM) 在患者管理和治疗发展方面构成了重大挑战.
研究的目的:
- 评估 MBM 患者在未来临床试验中的招生率.
- 确定影响MBM患者被排除或纳入试验方案的因素.
主要方法:
- 对黑色素瘤前性临床试验的审查.
- 对患者资格标准的分析,重点关注中枢神经系统疾病状态.
- 与MBM患者纳入相关因素的统计评估.
主要成果:
- 显著的大多数试验 (69.3%) 基于中枢神经系统疾病排除了MBM患者.
- 排除标准经常影响晚期黑色素瘤患者.
- 不使用免疫治疗的试验,包括勒普托门病的试验和非药品赞助的试验显示了更高的MBM纳入率.
结论:
- 目前的临床试验设计对寻求获得新疗法的MBM患者构成障碍.
- 修订试验资格标准至关重要,以包括MBM患者.
- 改善试验包容性可以提高黑色素瘤脑转移患者的治疗选择和结果.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...


